The conference featured keynote addresses by eminent researchers from leading global institutions. Academics from prestigious universities in both the United Kingdom and India contributed to the event ...

Salesforce is set to release its fiscal fourth quarter earnings on Feb. 25. The catalyst on Tuesday was not directly specific to Salesforce -- it was caught up in a massive sell-off, as the S&P 500 ...

Salesforce (CRM) secured a 10-year $5.6B Army contract generating $560M annually through its defense subsidiary. Salesforce stock dropped 33.7% over the past year despite beating Q3 earnings estimates ...

Salesforce (CRM) stock should be on your radar. Here’s why – it is presently trading within the support range ($210.50 – $232.66), levels from which it has significantly rebounded in the past. Over ...

Software stocks haven’t been able to shake off the narrative of artificial-intelligence disruption. In fact, those concerns seem to be deepening. Back To Top ...

Salesforce on Tuesday launched an entirely rebuilt version of Slackbot, the company's workplace assistant, transforming it from a simple notification tool into what executives describe as a fully ...

Salesforce topped estimates on the bottom line and raised its guidance. Its Agentforce AI platform is gaining traction. 2026 could be a big year for AI software stocks. Salesforce also touted strong ...

Salesforce, Inc.'s fiscal Q3 outperformance demonstrates ongoing execution consistency on Agentforce-led monetization. However, the stock remains undervalued, mispricing the broader economic ...

Kara Greenberg is a senior news editor for Investopedia, where she does work writing, editing, and assigning daily markets and investing news. Prior to joining Investopedia, Kara was a researcher and ...

Despite the fact that Salesforce CEO Marc Benioff talks about AI nonstop, regularly chimes in on the AI news of the day, and endlessly pushes his company’s AI platform, he seems worried that people ...

SAN FRANCISCO--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world’s #1 CRM, today announced that AstraZeneca (LSE/STO/Nasdaq: AZN), a global, science-led biopharmaceutical company, has selected ...